Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Novartis Healthcare Private Limited is a global healthcare company that develops and markets innovative medicines and treatments across various therapeutic areas. It offers products in fields such as oncology, cardiology, immunology, and neuropsychiatry, addressing critical health challenges and improving patient outcomes through cutting-edge research and development.
Novartis Healthcare Private Limited, is an unlisted private company incorporated on 13 October, 1997. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 6.00 cr and the total paid-up capital is INR 6.00 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Pushpa Kanta Adhikary | 09631602 | 4 years |
| Managing Director | Amitabh Dube | 09711248 | 3 years |
| Director | Sadhna Joglekar | 08869396 | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | 3,916.3 | 4,032.0 | 4,725.5 | 5,313.9 | 5,367.8 |
| Operating profit | 556.5 | 585.8 | 683.0 | 712.1 | 754.2 |
| Net profit | 237.4 | 252.6 | 344.6 | 381.5 | 565.9 |
| Gross margin | 72.9 | 80.5 | 82.0 | 81.8 | 83.9 |
| Operating margin | 14.2 | 14.5 | 14.4 | 13.4 | 14.1 |
| Net margin | 6.0 | 6.2 | 7.3 | 7.1 | 10.2 |
| Networth | 1,122.3 | 877.9 | 1,198.2 | 769.1 | 591.9 |
| Borrowings | - | 81.0 | - | - | - |
| Assets | 2,671.4 | 2,440.4 | 2,830.2 | 2,589.0 | 2,343.7 |
| Debt to equity | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Current ratio | 1.5 | 1.4 | 1.8 | 1.4 | 1.4 |
| ROE | 21.1 | 28.8 | 28.8 | 49.6 | 95.6 |
| Days payable | 196.0 | 195.0 | 177.0 | 170.0 | 129.0 |
| WC days | 43.0 | 38.0 | 59.0 | 32.0 | 27.0 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 |
| Reserves | 1,116.3 | 871.9 | 1,192.2 | 763.1 | 585.9 |
| Borrowings + | - | 81.0 | - | - | - |
| Long term borrowings | - | - | - | - | - |
| Short term borrowings | - | 81.0 | - | - | - |
| Trade payables + | 570.8 | 420.0 | 412.7 | 450.3 | 305.7 |
| Days payable | 196.0 | 195.0 | 177.0 | 170.0 | 129.0 |
| Other liabilities + | 1,549.1 | 1,481.5 | 1,632.0 | 1,819.9 | 1,751.7 |
| Other non-current liabilities | 565.0 | 592.8 | 673.0 | 716.5 | 719.9 |
| Other current liabilities | 413.2 | 468.7 | 546.3 | 653.1 | 726.1 |
| Total liabilities | 2,671.4 | 2,440.4 | 2,830.2 | 2,589.0 | 2,343.7 |
| Fixed Assets + | 821.3 | 685.4 | 633.6 | 426.4 | 347.4 |
| Tangible assets | 749.2 | 665.7 | 614.0 | 416.5 | 319.9 |
| CWIP | 69.1 | 16.7 | 16.6 | 6.9 | 24.5 |
| Intangible assets | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 |
| LT loans and advances | - | - | - | - | - |
| Other non-current assets | 406.6 | 367.9 | 476.6 | 597.6 | 565.5 |
| Current assets + | 1,443.5 | 1,387.1 | 1,720.0 | 1,565.0 | 1,430.7 |
| Inventories | 294.2 | 291.5 | 165.0 | 240.0 | 228.8 |
| Trade receivables | 679.5 | 597.8 | 813.6 | 777.9 | 661.7 |
| Cash and cash equivalents | 4.2 | 136.9 | 365.3 | 60.3 | 317.4 |
| ST loans and advances | - | - | - | - | - |
| Other current assets | 465.5 | 361.0 | 376.1 | 486.7 | 222.9 |
| Total assets | 2,671.4 | 2,440.4 | 2,830.2 | 2,589.0 | 2,343.7 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | 3,916.3 | 4,032.0 | 4,725.5 | 5,313.9 | 5,367.8 |
| Sales growth % | 14.82 | 2.95 | 17.2 | 12.45 | 1.01 |
| Expenses + | 3,566.2 | 3,680.0 | 4,275.6 | 4,841.0 | 4,794.4 |
| Cost of goods | 1,060.3 | 787.1 | 851.1 | 966.0 | 862.8 |
| Employee cost | 1,618.9 | 2,015.5 | 2,474.8 | 2,844.4 | 2,997.3 |
| Other costs | 680.5 | 643.7 | 716.6 | 791.4 | 753.5 |
| Operating profit + | 556.5 | 585.8 | 683.0 | 712.1 | 754.2 |
| Operating margin % | 14.2 | 14.5 | 14.4 | 13.4 | 14.1 |
| Other income | 20.1 | 15.1 | 17.4 | 51.9 | 188.5 |
| Interest | 42.7 | 47.6 | 38.4 | 37.7 | 26.2 |
| Depreciation | 163.8 | 186.2 | 194.6 | 201.5 | 154.7 |
| Exceptional items | - | - | - | - | - |
| Profit before tax | 370.2 | 367.1 | 467.3 | 524.8 | 761.8 |
| Tax | 132.8 | 114.5 | 122.7 | 143.2 | 195.9 |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | 237.4 | 252.6 | 344.6 | 381.5 | 565.9 |
| Net margin % | 6.0 | 6.2 | 7.3 | 7.1 | 10.2 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Net Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Debt/Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Assets/Equity | 2.4 | 2.8 | 2.4 | 3.4 | 4.0 |
| Liquidity + | |||||
| Current Ratio | 1.5 | 1.4 | 1.8 | 1.4 | 1.4 |
| Quick Ratio | 1.2 | 1.1 | 1.6 | 1.2 | 1.2 |
| Interest Coverage | 13.0 | 12.3 | 17.8 | 18.9 | 28.8 |
| Performance | |||||
| Gross Margin | 72.9 | 80.5 | 82.0 | 81.8 | 83.9 |
| Operating Margin | 14.2 | 14.5 | 14.4 | 13.4 | 14.1 |
| Net Margin | 6.0 | 6.2 | 7.3 | 7.1 | 10.2 |
| Return + | |||||
| Return on Equity | 21.1 | 28.8 | 28.8 | 49.6 | 95.6 |
| Pre-tax ROCE | 30.7 | 36.2 | 35.0 | 57.5 | 80.3 |
| Return on Assets | 8.9 | 10.3 | 12.2 | 14.7 | 24.1 |
| Pre-tax ROIC | 35.0 | 45.5 | 40.8 | 66.4 | 101.3 |
| Efficiency + | |||||
| Days Payable | 196.0 | 195.0 | 177.0 | 170.0 | 129.0 |
| Days Inventory | 101.0 | 135.0 | 71.0 | 91.0 | 97.0 |
| Days Receivable | 63.0 | 54.0 | 63.0 | 53.0 | 45.0 |
| Fixed Asset Turnover | 4.8 | 5.9 | 7.5 | 12.5 | 15.4 |
| Total Asset Turnover | 1.5 | 1.6 | 1.7 | 2.0 | 2.3 |
| Working Capital | |||||
| Cash Conversion Cycle | -32.0 | -6.0 | -43.0 | -26.0 | 13.0 |
| Working Capital Days | 43.0 | 38.0 | 59.0 | 32.0 | 27.0 |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SASH GETAWAYS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| ALTIUS INFINITE LLP |
Active
|
1.0 L | 1 | Maharashtra |
Read more
The incorporation date of NOVARTIS HEALTHCARE PRIVATE LIMITED is 13 October, 1997
The authorized share capital of NOVARTIS HEALTHCARE PRIVATE LIMITED is INR ₹ 6.0 Cr.
The paid-up capital of NOVARTIS HEALTHCARE PRIVATE LIMITED is INR ₹ 6.0 Cr.
The registered address of NOVARTIS HEALTHCARE PRIVATE LIMITED is Inspire BKC 7th Floor Bandra Kurla Complex, Bandra East, Bandra(East), Mumbai, Bandra, Maharashtra, India, 400051 - 400051
The CIN number of NOVARTIS HEALTHCARE PRIVATE LIMITED is U15202MH1997PTC111257.